ABAC Therapeutics

Spain
Barcelona, Catalonia, Spain
(+34) 93 230 11 54 ★

Company profile

ABAC Therapeutics company profile

ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximize the chance of success in clinical development.

Business identity

Phone number
(+34) 93 230 11 54
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2014-01-01

Headquarters

Headquarters
Barcelona, Catalonia, Spain
Postal code
08950
Country code
ES
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$20M
Last funding
Series A / $20M / 2018-02-15
Last equity funding
Series A / $20M
Investors
5
Lead investors
1
Founders
2
Articles
2

Founders and investors

Founders

Albert PalomerDomingo Gargallo-Viola

Lead investors

Pontifax

Investors

Criteria Venture TechDebiopharm Innovation FundGlobal health sciences venture fundGrupo Ferrer InternacionalPontifax

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.